Mark Lawler: Financial discrimination against cancer survivors

Mark Lawler, Chair in Translational Cancer Genomics at Queen’s University Belfast, shared a post on X:

“Our paper on financial discrimination against cancer survivors and our data-informed solution makes featured article in this September’s The Lancet Oncology.”

Ending financial discrimination for cancer survivors: embedding the Right to be Forgotten in legislation across Europe

Authors: Mark Lawler, Grazia Scocca, Françoise Meunier

Source: Mark Lawler/X

Dr. Mark Lawler is the Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, Centre for Cancer Research and Cell Biology. He is also a Visiting Professor in Human Genetics and Molecular Medicine at the University of Chieti Pescara, Italy. His specialties include genetics, molecular medicine, cancer biology, drug discovery, graduate education, bioethics, science policy, art therapy, and public perception of science.